Effective treatment of beta-thalassemia intermedia during pregnancy with rHuEpo. A case report

dc.contributor.authorLialios, G.en
dc.contributor.authorMakrydimas, G.en
dc.contributor.authorTsanadis, G.en
dc.contributor.authorLolis, D.en
dc.contributor.authorBourantas, K.en
dc.date.accessioned2015-11-24T19:22:09Z
dc.date.available2015-11-24T19:22:09Z
dc.identifier.issn0026-4784-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22147
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectErythropoietin/*therapeutic useen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectInfant, Newbornen
dc.subjectMaleen
dc.subjectPregnancyen
dc.subjectPregnancy Complications, Hematologic/*drug therapyen
dc.subjectRecombinant Proteinsen
dc.subjectbeta-Thalassemia/*drug therapyen
dc.titleEffective treatment of beta-thalassemia intermedia during pregnancy with rHuEpo. A case reporten
heal.abstractThe anemia of pregnancy in presence of beta-thalassemia intermedia usually aggravates pregnancy procedure. In the present study we investigated whether the administration of recombinant human erythropoietin (rHuEpo) recombinant human erythropoietin in combination with iron and folic acid may ameliorate blood indices as an alternative choice to blood transfusion.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/10851861-
heal.journalNameMinerva Ginecolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2000-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: